Genome-wide screening and identification of antigens for rickettsial vaccine development

FEMS Immunology and Medical Microbiology

Volumn 64, Issue 1, 2012, Pages 115-119

  Palmer, Guy H ^a   Brown, Wendy C ^a   Noh, Susan M ^b   Brayton, Kelly A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Genome wide; Immunization; Proteomics; Rickettsia; Vaccines

Indexed keywords

ANAPLASMOSIS VACCINE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN; OUTER MEMBRANE PROTEIN;

ANAPLASMA MARGINALE; ANAPLASMOSIS; ANTIGEN DETECTION; ARTICLE; BACTERIAL GENETICS; CD4+ T LYMPHOCYTE; DENSITY GRADIENT CENTRIFUGATION; GENETIC VARIABILITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION;

ANAPLASMA MARGINALE; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; COMPUTATIONAL BIOLOGY; GENOME, BACTERIAL; HUMANS; MASS SCREENING; RICKETTSIAL VACCINES;

EID: 84855659201     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00878.x     Document Type: Article

References (25)

1. Agnes JA, Brayton KA, LaFollett M, Norimine J, Brown WC & Palmer GH (2011) Identification of Anaplasma marginale outer membrane protein antigens conserved between sensu stricto strains and the live Anaplasma marginale ss. centrale vaccine. Infect Immun 79: 1311-1318.
2. Bock RE & de Vos AJ (2001) Immunity following use of Australian tick fever vaccine: a review of the evidence. Aust Vet J 79: 832-839.
3. Brayton KA, Kappmeyer LS, Herndon DR, Dark MJ, Tibbals DL, Palmer GH, McGuire TC & Knowles DP (2005) Complete genome sequencing of Anaplasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins. P Natl Acad Sci USA 102: 844-849.
4. + T lymphocyte and IgG2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect Immun 66: 5406-5413.
5. + T lymphocyte epitopes that elicit strong recall responses. J Immunol 166: 1114-1125.
6. Dark MJ, Herndon DR, Kappmeyer LS, Gonzales MP, Nordeen E, Palmer GH, Knowles DP & Brayton KA (2009) Conservation in the face of diversity: multistrain analysis of an intracellular bacterium. BMC Genomics 10: 16-28.
7. Dark MJ, Al-Khedery B & Barbet AF (2011) Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale. Vaccine 29: 4923-4932.
8. Futse JE, Brayton KA, Dark MJ, Knowles DP & Palmer GH (2008) Superinfection as a driver of genomic diversification in antigenically variant pathogens. P Natl Acad Sci USA 105: 2123-2127.
9. Galletti MFB, Ueti MW, Knowles DP, Brayton KA & Palmer GH (2009) Independence of high and low transmission efficiency Anaplasma marginale strains in the tick vector following simultaneous acquisition by feeding on a superinfected mammalian reservoir host. Infect Immun 77: 1459-1464.
10. Gallimore A, Dumrese T, Hengartner H, Zinkernagel RM & Rammensee HG (1998) Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med 187: 1647-1657.
11. Herndon DR, Palmer GH, Shkap V, Knowles DP & Brayton KA (2010) Complete genome sequence of Anaplasma marginale ss. centrale. J Bacteriol 192: 379-380.
12. Kocan KM, de la Fuente J, Gugliemone AA & Melendez RD (2003) Antigens and alternatives for control of Anaplasma marginale infection in cattle. Clin Microbiol Rev 16: 698-712.
13. Lopez JE, Siems WF, Palmer GH, Brayton KA, McGuire TC, Norimine J & Brown WC (2005) Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect Immun 73: 8109-8118.
14. Lopez JE, Palmer GH, Brayton KA, Dark MJ, Leach SE & Brown WC (2007) Immunogenicity of Anaplasma marginale type IV secretion 1 system proteins in a protective outer membrane vaccine. Infect Immun 75: 2333-2342.
15. Lopez JE, Beare PA, Heinzen RA, Norimine J, Lahmers KK, Palmer GH & Brown WC (2008) High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation. J Immunol Methods 332: 129-141.
16. Morgan C, Marthas M, Miller C et al. (2008) The use of non-human primate models in HIV vaccine development. PLoS Med 8: 1200-1204.
17. Noh SM, Brayton KA, Knowles DP, Agnes JT, Dark MJ, Brown WC, Baszler TV & Palmer GH (2006) Differential expression and sequence conservation of the Anaplasma marginale msp2 gene superfamily outer membrane proteins. Infect Immun 74: 3471-3479.
18. Noh SM, Brayton KA, Brown WC, Norimine J, Munske GR, Davitt CM & Palmer GH (2008) Composition of the surface proteome of Anaplasma marginale and its role in protective immunity induced by outer membrane immunization. Infect Immun 76: 2219-2226.
19. Oukka M, Manuguerra JC, Livaditis N, Tourdot S, Riche N, Vergnon I, Cordopatis P & Kosmatopoulos K (1996) Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J Immunol 157: 3039-3045.
20. Palmer GH, Rurangirwa FR, Kocan KM & Brown WC (1999) Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol Today 15: 281-286.
21. Pipano E (1995) Live vaccination against hemoparasitic diseases in livestock. Vet Parasitol 57: 213-231.
22. Rodriguez JL, Palmer GH, Knowles DP & Brayton KA (2005) Distinctly different msp2 pseudogene repertoires in Anaplasma marginale strains that are capable of superinfection. Gene 361: 127-132.
23. Sette A & Rappuoli R (2010) Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33: 530-541.
24. Tebele N, McGuire TC & Palmer GH (1991) Induction of protective immunity using Anaplasma marginale initial body membranes. Infect Immun 59: 3199-3204.
25. Theiler A (1911) First Report of the Director of Veterinary Research. Department of Agriculture, Union of South Africa, Johannesburg, South Africa, pp. 7-46.